069620.KS · 대웅제약
South Korea · RS rating 15 · As of 2026-10-14
| Price | 106,900.00 KRW |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 33 / 11 / 40 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 17 / 17 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +28.8% |
| Sales growth Q/Q | +18.7% |
| Distance from 52-week high | +44.9% |
| Market cap (USD) | $929.9M |